Innoviz Technologies Ltd. current report, Q3 FY2023

Business Context and Reporting Period

Innoviz Technologies Ltd., an Israel-based developer of automotive LiDAR technology, furnished this Form 6-K for August 2023. The filing reports a public offering of ordinary shares that closed on August 14, 2023.

Offering and Key Financial Metrics

ItemDetails
Shares offered26,000,000 ordinary shares
Offering price$2.50 per share
Gross proceeds$65.0 million, before underwriting discounts and estimated offering expenses
Underwriter option30-day option to purchase up to 3,900,000 additional shares for over-allotments
Net proceedsThe filing does not provide a clear net proceeds amount
Other financial metricsThe filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or guidance data

Material Changes Versus the Prior Comparable Period

The filing does not present comparative operating or financial results. The material transaction disclosed is the issuance of 26.0 million ordinary shares and the resulting gross capital raise of $65.0 million.

Terms, Risks, and Unusual Items

  • The offering was conducted under the Company’s effective Form F-3 registration statement.
  • The underwriting agreement includes customary representations, warranties, closing conditions, indemnification obligations, covenants, and termination provisions.
  • Shareholder dilution is an important consequence of the offering; the filing does not quantify the resulting percentage dilution.
  • Final proceeds will be reduced by underwriting discounts and offering expenses.
  • The underwriters may purchase up to an additional 3.9 million shares under the over-allotment option; the filing does not state whether that option was exercised.
  • No management outlook, operating guidance, contingencies, or business risks beyond the offering terms are provided in this filing.

Investor Verification Items

  • Verify the final number of shares issued, including any shares sold under the over-allotment option.
  • Verify net proceeds after underwriting discounts and offering expenses.
  • Assess the offering’s effect on shares outstanding and shareholder dilution.
  • Review the underwriting agreement filed as Exhibit 1.1 for detailed obligations and termination provisions.
  • Consult subsequent filings for the use of proceeds, liquidity position, operating results, and updated financing needs.